Cited by 70Attention Deficit Hyperactivity DisorderTraffic and Road SafetyNeuroethics, Human Enhancement, Biomedical Innovations

Long-Acting Methylphenidate Reduces Collision Rates of Young Adult Drivers With Attention-Deficit/Hyperactivity Disorder

Cox, Daniel J., Davis, Margaret, Mikami, Amori Yee, Singh, Harsimran, Merkel, Richard L., Burket, Roger·2012·Journal of Clinical Psychopharmacology

Abstract

This study investigated whether methylphenidate delivered through a long-acting transdermal system (MTS) would reduce collision rates of young adult drivers with attention-deficit/hyperactivity disorder (ADHD).Seventeen young adults completing the study (mean [SD] age, 20.82 [2.40] years; 14 men and 13 white) met the following inclusion criteria: ADHD diagnoses but not routinely taking ADHD medication, previously responsive to ADHD medication, active drivers with more than 1 collision or citation in the past 2 years, and no significant comorbidities. In this open-labeled, crossover design drivers were randomly assigned either to the no-medication condition for 3 months and then MTS for 3 months or to the reverse sequence. In-car video monitoring of routine driving occurred during these 6 months. At baseline and after each condition, participants completed the Conners Adult ADHD Rating Scale and the Cox Assessment of Risky Driving Scale, and their blood pressure, heart rate, and body weight were monitored.Compared with the no-medication condition, participants in the MTS condition self-reported fewer total ADHD (P < 0.04) and inattentive symptoms (P = 0.014) and a trend for risky driving behaviors (P = 0.059) and had fewer video-recorded collisions (P < 0.005) and other problematic driving events. There were no significant changes in blood pressure, heart rate, or body weight across conditions or any significant skin reactions to the MTS patch.This is the first study demonstrating that long-acting methylphenidate improves activities of daily living among young adults with ADHD. Specifically, methylphenidate improved safety in routine driving while reducing ADHD symptoms with minimal adverse effects.

Integrity signals

Registry

Crossref · 10.1097/jcp.0b013e3182496dc5

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 13 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Cox, D. J., Davis, M., Mikami, A. Y., Singh, H., Merkel, R. L., & Burket, R.
Affiliations
  • University of Virginia Health System (US)
  • University of Virginia (US)
Corresponding author
  • Cox, Daniel J.
  • Davis, Margaret
  • Singh, Harsimran
  • Merkel, Richard L.
  • Burket, Roger
Venue
Journal of Clinical Psychopharmacology
Published
2012-04
Volume
32
Issue
2
Pages
225-230
ISSN
0271-0749 (ISSN-L)
OpenAlex
W1978886574
Cited by
69
References
13
Citations by year
2026: 2 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 6 · 2019: 3 · 2018: 4 · 2017: 9 · 2016: 6 · 2015: 7 · 2014: 6 · 2013: 8 · 2012: 1
FWCI
5.01
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Physical Sciences › Engineering › Safety, Risk, Reliability and Quality › Traffic and Road Safety
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
Keywords
methylphenidate, attention deficit hyperactivity disorder, young adult drivers, driving safety, traffic accidents, risky driving behavior, inattention, ADHD medication
MeSH terms
Activities of Daily Living, Adolescent, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Automobile Driving, Delayed-Action Preparations, Female, Humans, Male, Methylphenidate, Psychiatric Status Rating Scales, Psychometrics, Risk-Taking, Video Recording, Treatment Outcome, Cross-Over Studies, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review